A CASE OF MONOCLONAL ANTIBODY (RITUXIMAB) INDUCED POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS. (2024). Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, 31(1), 698-704. https://jrdiabet.ro/index.php/RJDNMD/article/view/335